Ustekinumab-aekn 90 mg/mL
ustekinumab-aekn · INJECTION, SOLUTION · Teva Pharmaceuticals USA, Inc.
No Recall History
Plain English
Ustekinumab-aekn is a injection, solution containing ustekinumab-aekn at 90 mg/mL, taken subcutaneous. Manufactured by Teva Pharmaceuticals USA, Inc..
Key Facts
- Brand Name
- Ustekinumab-aekn
- Generic Name
- ustekinumab-aekn
- NDC Code (Product)
51759-710- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Strength
- 90 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761343
- Marketing Start
- 06/02/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Ustekinumab-aekn used for?
Ustekinumab-aekn contains ustekinumab-aekn. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Ustekinumab-aekn a controlled substance?
Ustekinumab-aekn is not classified as a controlled substance by the DEA.
What is the generic name for Ustekinumab-aekn?
The generic name for Ustekinumab-aekn is ustekinumab-aekn. There are 4 other brand versions of ustekinumab-aekn.
What is the NDC code for Ustekinumab-aekn 90 mg/mL?
The NDC (National Drug Code) for Ustekinumab-aekn 90 mg/mL is 51759-710, listed by Teva Pharmaceuticals USA, Inc..